BioAgilytix company, announced the opening of a new Australian laboratory in Sydney, expanding its national footprint to four ...
SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) announce a collaboration to advance new prostate ...
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...
Five of the twelve Presidential Symposium late-breakers in Madrid trace back to molecules discovered in China. Here is what ...
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York.
RESTORE-3 study demonstrates a 60.4% proptosis response rate versus 23.5% with placebo at Week 24, highlighting the potential ...
Agreement grants Theramex exclusive commercialisation rights across Europe, Australia, New Zealand and Turkey for the non-surgical HPV-related cervical precancer treatment, with $15 million upfront ...
Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, announced it has signed a Memorandum ...
FDA grants Fast Track designation to NVC-001 as the SUNBEAM-LMNA trial evaluates the safety and potential of a one-time gene therapy for aggressive inherited heart disease with no approved ...
Clearance strengthens RingConn’s position in the US wearable health technology market, supporting its expansion in SpO2 ...
The initiative combines NVIDIA’s accelerated computing ecosystem with GenScript’s laboratory validation expertise, offering ...
(9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results